West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 276,800 | 271,400 | 281,800 | 274,700 | 293,400 |
| Cost of Goods | 198,800 | 196,700 | 198,600 | 192,500 | 209,500 |
| Gross Profit | 78,000 | 74,700 | 83,200 | 82,200 | 83,900 |
| Operating Expenses | 72,800 | 50,100 | 53,300 | 53,800 | 62,700 |
| Operating Income | 6,000 | 25,300 | 30,500 | 28,900 | 21,700 |
| Interest Expense | 4,700 | 4,200 | 3,900 | 4,000 | 4,000 |
| Other Income | 1,000 | 1,200 | 1,700 | 1,100 | 1,500 |
| Pre-tax Income | 2,300 | 22,300 | 28,300 | 26,000 | 19,200 |
| Income Tax | -3,700 | 4,500 | 6,600 | 6,200 | -1,100 |
| Net Income Continuous | 6,000 | 17,800 | 21,700 | 19,800 | 20,300 |
| Net Income | $6,000 | $17,800 | $21,700 | $19,800 | $20,300 |
| EPS Basic Total Ops | 0.09 | 0.27 | 0.33 | 0.30 | 0.31 |
| EPS Basic Continuous Ops | 0.09 | 0.27 | 0.33 | 0.30 | 0.31 |
| EPS Diluted Total Ops | 0.10 | 0.26 | 0.31 | 0.29 | 0.30 |
| EPS Diluted Continuous Ops | 0.08 | 0.24 | 0.30 | 0.27 | 0.28 |
| EBITDA(a) | $25,500 | $43,600 | $48,200 | $46,600 | $40,000 |